HAL (France)open access
Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort
Cancer genomics, 0, Translational research, 2, 1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 250332
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.